However, there was no discernible difference in autophagy levels between pancreatic cancer cells treated with MitoQ and those with NLRP4 knockdown (Fig. 7c–e), suggesting that NLRP4-induced autophagy is mediated by ROS production. This evidence concerns the gene NLRP4 and pancreatic neoplasm.